Evidence map›Paper›PMID 36889786›Full record

SynthesisEuropean respiratory review : an official journal of the European Respiratory Society2023

The role of smoking in COVID-19 progression: a comprehensive meta-analysis.

Silvano Gallus, Marco Scala, Irene Possenti, Carlotta Micaela Jarach, Luke Clancy, Esteve Fernandez, Giuseppe Gorini, Giulia Carreras, Maria Chiara Malevolti, Alison Commar and 4 more

Open access · diamondAbstract readMeta-AnalysisReview
In one paragraph

Synthesis in European respiratory review : an official journal of the European Respiratory Society, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
9.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it, 48 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Observational
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 4 countries.

Silvano GallusDepartment of Environmental Health Sciences, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy silvano.gallus@marionegri.it.ORCID https://orcid.org/0000-0002-8967-0400
Marco ScalaDepartment of Environmental Health Sciences, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
Irene PossentiDepartment of Environmental Health Sciences, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
Carlotta Micaela JarachDepartment of Environmental Health Sciences, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
Luke ClancyTobaccoFree Research Institute Ireland, TU Dublin, Ireland.ORCID https://orcid.org/0000-0003-2407-2263
Esteve FernandezTobacco Control Unit, WHO Collaborating Centre for Tobacco Control, Institut Català d'Oncologia-ICO, L'Hospitalet de Llobregat, Barcelona, Spain.ORCID https://orcid.org/0000-0003-4239-723X
Giuseppe GoriniIstituto per lo Studio, la Prevenzione e la Rete Oncologica (ISPRO), Florence, Italy.ORCID https://orcid.org/0000-0002-1413-5948
Giulia CarrerasIstituto per lo Studio, la Prevenzione e la Rete Oncologica (ISPRO), Florence, Italy.
Maria Chiara MalevoltiIstituto per lo Studio, la Prevenzione e la Rete Oncologica (ISPRO), Florence, Italy.
Alison CommarWorld Health Organization, Tobacco Free Initiative, Geneva, Switzerland.
Ranti FayokunWorld Health Organization, Tobacco Free Initiative, Geneva, Switzerland.
Hebe N GoudaWorld Health Organization, Tobacco Free Initiative, Geneva, Switzerland.
Vinayak M PrasadWorld Health Organization, Tobacco Free Initiative, Geneva, Switzerland.
Alessandra LugoDepartment of Environmental Health Sciences, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.ORCID https://orcid.org/0000-0002-4297-6496
Mario Negri Institute for Pharmacological Research · ITWorld Health Organization · CHIstituto per lo Studio e la Prevenzione Oncologica · ITBellvitge University Hospital · ESTobaccoFree Research Institute · IE

Funding

World Health Organization 001
6 · The paper itself

Abstract

The association between current smoking and coronavirus disease 2019 (COVID-19) progression remains uncertain. We aim to provide up-to-date evidence of the role of cigarette smoking in COVID-19 hospitalisation, severity and mortality. On 23 February 2022 we conducted an umbrella review and a traditional systematic review

Indexed as

COVID-19HumansOdds RatioRisk FactorsSARS-CoV-2Smoking

Identifiers

PMID36889786
PMCPMC10032583
OpenAlexW4323565685

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.